Magenta Therapeutics Inc
Biotechnology
Healthcare
MGTA
58.82 M shares
NASDAQ US
traded
02 Dec 2022
listed
yes
open
1.14
52 week high
8.33
high
1.35
52 week low
1.32
previous Close
1.55
P/E ratio
market cap
110 M
div yield
0
net incoming
-17.27 M
24.75 %
net profit margin
-1727100000.00 %
0.00 %
operating incoming
-18.08 M
24.13 %
net change in cash
-16.93 M
71.72 %
cash on hand
54.83 M
-23.60 %
top